Corcept Therapeutics Incorporated
CORT
Rang în acțiuni
#1698
Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo... Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Its primary commercial offering is Korlym (mifepristone) tablets, an oral medication taken once daily. Korlym is prescribed for adult patients diagnosed with endogenous Cushing's syndrome who suffer from hyperglycemia due to hypercortisolism, particularly those with type 2 diabetes or glucose intolerance, and for whom surgical options have either failed or are not viable. The company's development pipeline is robust, featuring relacorilant, which is being advanced for Cushing's syndrome. It is also investigating a combination of relacorilant with nab-paclitaxel; this pairing has concluded Phase II clinical trials for advanced ovarian tumors and is additionally being studied for conditions involving cortisol excess. Furthermore, Corcept is developing distinct selective cortisol modulators for specific indications such as metastatic castration-resistant prostate cancer and antipsychotic-induced weight gain, alongside research into FKBP5 gene expression assays.
Preț acțiune
$116.39
Ultima sincronizare: 2026-10-21
Capitalizare de piață
$12.58B
Schimbare (1 zi)
-0.05%
Schimbare (1 an)
58.03%
Țară
US
Tranzacționează Corcept Therapeutics Incorporated (CORT)
Categorie
Healthcare
Istoric al prețului acțiunii pentru Corcept Therapeutics Incorporated (CORT)
Cel mai mare preț de închidere: $116.99 pe 2026-10-01
Cel mai mic preț de închidere: $11.30 pe 2004-04-01
Cel mai mic preț de închidere: $11.30 pe 2004-04-01
Istoric al prețului acțiunii pentru Corcept Therapeutics Incorporated din 2004 până în 2026
Evoluția anuală a prețului acțiunii
| An | Performanță |
|---|---|
| 2026 (TTM) | -9.40% |
| 2025 | 45.40% |
| 2024 | 87.74% |
| 2023 | 37.96% |
| 2022 | 8.70% |
| 2021 | -22.54% |
| 2020 | 97.11% |
| 2019 | -8.02% |
| 2018 | -18.04% |
| 2017 | 113.00% |
| 2016 | 61.25% |
| 2015 | 59.73% |
| 2014 | 23.32% |
| 2013 | 64.30% |
| 2012 | -54.17% |
| 2011 | -17.98% |
| 2010 | 63.22% |
| 2009 | 127.09% |
| 2008 | -61.78% |
| 2007 | 209.70% |
| 2006 | -77.05% |
| 2005 | -25.76% |
| 2004 | 0.00% |
Prețul acțiunii pentru companii similare sau concurente
| Companie | Preț acțiune | Variație 1an% | Țara |
|---|---|---|---|
| $62.20 | 68.82% |
US
|
|
| $46.29 | 37.83% |
SE
|
|
| $171.04 | 23.67% |
FR
|
|
| $59.46 | -0.57% |
IT
|
|
| $0.65 | -29.58% |
HK
|
